Laura Lovett
Curi Bio raises $10M Series A to advance Mantarry stem cell drug-discovery platform
Seattle startup Curi Bio raised $10 million in Series A to advance its Mantarry stem cell-focused drug discovery platform and expand the business.
Seattle startup Curi Bio raised $10 million in Series A to advance its Mantarry stem cell-focused drug discovery platform and expand the business.